NCT06457295Completed
Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
the aim of this study is to assess the impact of duration of DM on OCTA parameters in diabetic patients without clinical Diabetic retinopathy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 4 Jun 2024
- Start date
- 20 Dec 2024
- Primary completion date
- 1 Aug 2025
- Lead sponsor
- Sohag University
- Diseases
- Diabetic eye disease
- NCT number
- NCT06457295
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 20 Dec 2024 to the primary completion date, 1 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Ocular history : any history of significant ocular injury or disease that could affect the retinal microvasculature such as retinal vascular occlusion, glaucoma, or vitreo-macular disease, as such conditions have also been noted to show sub-clinical OCTA changes \[13, 14\].
Other
- Fundus examination: macular edema or any other signs of clinical retinopathy
Who the study is looking for
- Type of DM: Type 2.
- Fundus examination: no macular edema or other signs of clinical retinopathy
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag University Hospital Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.